The differential analysis showed that in the osteosarcoma group, the expression of EPYC and PANX3 was obviously elevated, whereas the expression of CD36, CLDN11 and STOM was markedly decreased (Fig. 12A). This evidence concerns the gene CLDN11 and osteosarcoma.